Phase III Study of BBV154 Intranasal Vaccine in Healthy Volunteers

Clinical trial NCT05522335 · UNKNOWN

Trial details

NCT number: NCT05522335
Sponsor: Bharat Biotech International Limited
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

COVID-19 Respiratory Infection

Start date: 2022-04-16
Primary completion: 2022-07-19
Enrollment: 3160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.